Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Chinese Pla General Hospital has 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are assigned to 2 distinct examiners but are located within 1 distinct art unit. LY, KRISTINA ELISABETH is the busiest examiner, with 1 pending action currently under review.
This means the pending office actions are divided equally between the examiners. The fact that the examiners operate within 1 distinct art unit provides a level of consistency in the technical oversight of the portfolio. Practitioners can analyze the art unit's general trends to inform their approach for both pending actions. While LY, KRISTINA ELISABETH handles half of the current workload, the overall strategy must address the specific requirements of the Biotechnology & Pharmaceuticals sector across the examiners. This arrangement allows for the observation of different examiner styles within a single art unit. The presence of multiple examiners ensures that the prosecution of the pending office actions is not overly concentrated. This structure simplifies the management of the company's current patent office interactions while providing a diversified review process.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LY, KRISTINA ELISABETH | 1 | 37.5% | +100.0% |
| ABEYRATNE-PERERA, HASHANTHI KOMITIGE | 1 | 0.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18708771 | SARS-COV-2 S PROTEIN POLYPEPTIDE ANTIGEN AND APPLICATION THEREOF | LY, KRISTINA ELISABETH | — |
| 18603959 | Autophagosome For Promoting Healing of Diabetic Wound, and Preparation Method and Use Thereof | ABEYRATNE-PERERA, HASHANTHI KOMITIGE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18708771 | SARS-COV-2 S PROTEIN POLYPEPTIDE ANTIGEN AND APPLICATION THEREOF | LY, KRISTINA ELISABETH | — |
| Art Unit | Apps |
|---|---|
| 1632 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18708771 | SARS-COV-2 S PROTEIN POLYPEPTIDE ANTIGEN AND APPLICATION THEREOF | LY, KRISTINA ELISABETH | — | §102§103§112 | Non-Final OA | — | Pending | May 09, 2024 |
| 18603959 | Autophagosome For Promoting Healing of Diabetic Wound, and Preparation Method and Use Thereof | ABEYRATNE-PERERA, HASHANTHI KOMITIGE | 1632 | §101§102§103§112 | Non-Final OA | — | Pending | Mar 13, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial